Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Credo Technology Group Holding Ltd heads into its fiscal Q4 print tonight having given back ground from last week's peak, with the stock at $226.10 — down 4% on the day but still up 23% over the past month and sitting well above where any analyst on the Street has set a target.
The day's pullback is the first real wrinkle in a story that has been relentlessly bullish. CRDO hit $236 on Friday; it is now roughly $10 below that. Options positioning reflects a mild shift toward calls: the put/call ratio has eased to 0.80, about 1.3 standard deviations below its 20-day average of 0.88. That is more bullish than typical — traders are not hedging into the print the way they might be expected to after a 23% monthly run. The borrow market adds nothing to the tension. Availability has expanded dramatically over the past week to nearly 4,961% — meaning the lending pool is essentially empty of demand relative to supply — and cost to borrow has fallen 27% over the same period to just 0.33%. Short interest, at 5.47% of the free float, has edged up fractionally from the May 26 low but remains well below the mid-May peak near 5.9%. There is no squeeze dynamic here, and no sign of fresh short conviction building into the report.
The central debate is not about growth — it is about whether the valuation has run ahead of even the most optimistic read of the business. The Street's mean price target is $221, now below Monday's close. Mizuho's Vijay Rakesh raised his target to $260 just yesterday, maintaining Outperform — the most aggressive published number in the current cycle and one of the few targets sitting above the stock. Goldman Sachs raised to $170 in mid-April and is already deeply underwater. The bull case rests on >75% revenue growth in FY27, driven by hyperscaler adoption of AECs and a $500M-plus optical division contribution from the DustPhotonics acquisition. Bears point to customer concentration risk, heavy reliance on outsourced manufacturing, and the upfront cost of integrating DustPhotonics — a combination that could weigh on margins even if top-line numbers impress. EPS momentum is exceptional, ranking in the 97th percentile on a 30-day basis, which tells you estimate revisions have been running hot. The earnings surprise history is more mixed at the 38th percentile — the company does not always beat by wide margins when it matters most.
One institutional data point is worth noting. Point72 built a position of 7.5 million shares as of March 31, adding nearly 1.9 million in the quarter — a meaningful commitment from an active manager known for high-conviction positioning. BlackRock added roughly 1 million shares through April. On the insider side, the moves are all in one direction: Founder and CTO Lawrence Cheng sold approximately 18,000 shares on May 1 across multiple tranches, and CLO James Laufman sold 7,400 shares on May 19. Both are likely programmatic, but the 90-day net position across all insiders is a modest $14.9M of net selling — not alarming at this stock price, but not a vote of confidence either. After the March print drove a 17% one-day gain, tonight's report tests a stock that has already priced in much of that enthusiasm at a still-higher level.
The print is less about whether CRDO can grow at speed and more about whether the optical revenue ramp and margin trajectory justify a stock price that has outrun every analyst target except one set just 24 hours ago.
See the live data behind this article on ORTEX.
Open CRDO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
